BVF INC/IL: 13F holdings
CIK 10568072026Q2
| Positions | 44 |
|---|
| Reported value | $3.9bn |
|---|
| Filed | 2026-08-14 |
|---|
Change since last quarter
| Positions | 44 (+3 vs prior quarter) |
|---|
| Reported value | $3.9bn (+24.6%) |
|---|
Top 10 holdings
| Security | Shares | Value | Weight |
|---|
| RVMD REVOLUTION MEDICINES INC | 2,965,160 | $555.3m | 14.2% |
| KYMR KYMERA THERAPEUTICS INC | 3,872,052 | $444.0m | 11.4% |
| XOMA ROYALTY CORPORATION | 7,593,303 | $322.7m | 8.3% |
| MLTX MOONLAKE IMMUNOTHERAPEUTICS | 16,001,284 | $311.5m | 8.0% |
| GH RESEARCH PLC | 8,650,158 | $232.5m | 5.9% |
| GPCR STRUCTURE THERAPEUTICS INC | 3,366,823 | $180.7m | 4.6% |
| NKTR NEKTAR THERAPEUTICS | 2,391,075 | $166.9m | 4.3% |
| MIRM MIRUM PHARMACEUTICALS INC | 1,056,027 | $123.6m | 3.2% |
| XNCR XENCOR INC | 7,133,720 | $114.9m | 2.9% |
| ALKERMES PLC | 2,154,704 | $112.9m | 2.9% |
Get the full book
import finzdata as yf
yf.Client().manager_holdings(cik="1056807")
Every position, quarter by quarter since 2013, with adds, trims and exits, on the look-back bundles.
Get a free API keySee history bundlesDownload free samples